Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

Diabetes
on the net
Live

A leading online events and interactive learning platform for healthcare professionals managing diabetes.
Sign up now to engage with the experts.

TAKE A LOOK AT OUR

upcoming
online events

210628_Novo_oz_ry_thumbnail_v0c

fORward thinking in type 2 diabetes: Optimising adult care to improve outcomes

Tue 21 Sep 2021 | Tue 19 Oct 2021
+ additional dates


This promotional webcast series has been developed, organised and funded by Novo Nordisk for UK healthcare professionals only. Novo Nordisk product information will be discussed. Prescribing information and adverse events reporting will be available at this webcast series.

This promotional webinar was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and the speakers prior to broadcast. Editorial support for this webinar was provided by OmniaMed Communications.

Prescribing information for Suliqua® (insulin glargine 100 units/mL and lixisenatide) can accessed by clicking here.

This promotional webinar has been developed and funded by Lilly. Lilly products will be discussed at this online event. Prescribing information for Trulicity® (dulaglutide) can be accessed by Clicking here.  OmniaMed Communications has provided editorial, marketing and logistical support. Lilly is a registered trademark of Eli Lilly and Company © 2021 Eli Lilly and Company. All rights reserved.
PP-DG-GB-0910 | August 2021

This promotional webinar has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company and the speakers prior to the webinar. The speakers have received an honorarium to take part in this promotional webinar. Editorial support for this webinar has been provided by OmniaMed Communications.
Click here for prescribing and adverse event reporting details for:
Great Britain 
Northern Ireland 
Ireland 
PC-GB-105382 | September 2021
This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for Scotland-based healthcare professionals.

This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.
This promotional webinar was initiated and fully funded by Sanofi. The content has been reviewed and approved by the sponsoring company and the speakers prior to broadcast. Editorial support for this webinar was provided by OmniaMed Communications. Prescribing information for Suliqua® (insulin glargine 100 units/mL and lixisenatide) can accessed by clicking here.

TAKE A LOOK AT OUR

On-Demand
videos

PCDS Question Time 2021

On-demand webinars and resources to enable reflection and discussion

This virtual broadcast series has been funded by Boehringer Ingelheim. Boehringer Ingelheim has had no editorial input into, or influence over, the content of the webinar. PCDS is solely responsible for the content of the webinar and the selection of speakers.

abracadabra2021 (2)

21st Annual abracadabra diabetes nursing conference​

On-Demand videos from the annual conference



This on-demand content has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed, and prescribing information will be available.

12th Welsh Conference of the Primary Care Diabetes Society

On-demand webinars from the annual PCDS conference



This promotional resource is organised and funded by Novo Nordisk. The information presented is intended for UK-based healthcare professionals.

Time in range - is this the new gold standard?

Exploring the role of technology and modern insulins for improving glycaemic control in diabetes


This promotional resource is organised and funded by Novo Nordisk and Abbott. Marketing and organisational support has been provided by OmniaMed Communications. The information presented is intended for UK-based healthcare professionals. Adverse event reporting information and Prescribing Information will be available.

How to Optimise Remote Consultations in Diabetes

Speakers: Pam Brown & Jane Diggle


This broadcast was funded by Novo Nordisk. Novo Nordisk has had no editorial input into, or control over, the content of the webinar. PCDS is responsible for the content of the webinar and selection of speakers.

Virtual PCDS Smart Update in diabetes

Interpreting latest evidence and guidance to drive improved patient care


This independent programme has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. PCDS is responsible for the content of all materials and selection of speakers pertaining to this

This website is for healthcare professionals

This website is for UK and ROI healthcare professionals only. To continue, please confirm that you are a UK or ROI healthcare professional by clicking the ‘Confirm’ button below.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.